| | | | | Catalent Acquires Premier European Product Launch Site from Bristol-Myers Squibb | |
|
| | | | | Catalent recently announced the completion of the acquisition of the Bristol-Myers Squibb’s biologics, sterile, and oral solid dose product manufacturing and packaging facility in Anagni, Italy .
The state-of-the-art facility designed for late-phase tech transfers and commercial product launches has a track record of launching hundreds of new products across many therapies including cardiovascular, cancer, and hepatitis treatments. This facility will provide Catalent customers access to: |
|
|---|
| | |
| | | Comprehensive commercial packaging solutions with blister and bottling capabilitiesSerialization solutions to ensure product traceability throughout the global supply chainIntegrated digital printing and RFID tracking, enabling 48-hour turnaround to marketHighly automated warehousing
The Anagni facility complements Catalent’s existing European oral solid dose development and manufacturing network in:
Schorndorf, Germany Eberbach, Germany Nottingham, U.K. Swindon, U.K. Aprilia, Italy Beinheim, France |
|
| |
| | | | | | | Article: Planning Successful Product Launches | |
|
| | | | | | Developing and bringing a new drug to market is a long, expensive and uncertain process. Read this article published by Pharmaceutical technology to learn about proven strategies for a successful product launch, including cross-functional team collaboration, risk management and using the right project management tools. |
|
|---|
| | |
| | | | | Webinar: Flexible Manufacturing Strategies: What’s Best for Your Product? | |
|
| | | | | Pharmaceutical and biotechnology companies approach external development and manufacturing partners for solutions for their product’s specific needs. New products are increasingly complex and must be developed in shorter timelines to meet patient needs. With the rise in accelerated designations (i.e., orphan drugs, fast track, etc.), advanced manufacturing technologies and smaller batch sizes are becoming the trend. |
|
|---|
| | |
| | | | | Brochure: Customized Manufacturing Solutions | |
|
| | | | | | Manufacturing pharmaceutical, biologic and consumer health products is becoming ever more challenging. With more complex molecules, accelerated timelines, global requirements and regulatory complexities, planning for a scalable clinical solution, a successful launch and reliable commercial supply is a critical and complicated task. Learn how Catalent has the scale, the experience and the capacity across multiple dose form delivery technologies and global regions to meet your complex manufacturing needs and supply better treatments for your patients and consumers. |
|
|---|
| | |
| | | | | | Every molecule has a challenge. We have a solution. |
| | | | | | | | or call +1 877 891 9609 to speak with one of our experts today! |
| | |
| | | To unsubscribe or manage your subscriptions, please click here.
For more information call +1-866-720-3148 or in Europe 00800 88 55 6178, email us at [email protected], or visit our website www.catalent.com. And to learn more about Career opportunities across our global network, visit www.catalent.com/careers.
Catalent Pharma Solutions respects your privacy.
Links to third party sites are provided as a convenience only. Catalent makes no representation or warranty about the technology, security or any content available at these sites. Links are not intended to imply Catalent's affiliation or endorsement or the website, its owner(s) or the content. | | © 2020, Catalent Pharma Solutions, Inc. 14 Schoolhouse Road, Somerset, NJ 08873. All rights reserved. |
|
|
